Each week, we track the latest science, policy shifts, and market updates shaping the future of GLP‑1 drugs. Here’s what you need to know for the first week of August
Weekly RoundUp
2Articles
Stay on top of the latest GLP‑1 drug developments with this week’s most talked-about stories — from trial breakthroughs to market shifts and early-stage discoveries. Orforglipron shines in Phase III